Latest Ratios: P/E Ratio 13.4x · EV/EBITDA 9.5x · ROE 166.3%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $10.5B | $14.9B | $17.0B | $19.7B | $17.5B | $22.9B | $28.0B | $19.9B | $17.8B | $17.5B | $18.2B |
| Enterprise Value | $13.3B | $17.6B | $19.7B | $22.3B | $20.4B | $25.7B | $30.3B | $22.4B | $20.1B | $19.3B | $20.1B |
| P/E Ratio → | 13.37 | 18.42 | 60.65 | 132.53 | 37.80 | 32.24 | 29.85 | 24.23 | 21.64 | 25.00 | 28.13 |
| P/S Ratio | 1.48 | 2.10 | 2.40 | 2.67 | 2.46 | 3.12 | 4.17 | 3.20 | 2.91 | 2.93 | 3.16 |
| P/B Ratio | 22.47 | 30.96 | 34.62 | 50.90 | 23.96 | 38.69 | 30.84 | 35.55 | 24.51 | 32.34 | 61.37 |
| P/FCF | 13.85 | 19.61 | 35.26 | 21.24 | 32.65 | 24.24 | 21.68 | 25.28 | 22.82 | 27.52 | 30.08 |
| P/OCF | 10.74 | 15.21 | 24.51 | 17.06 | 22.22 | 17.95 | 18.12 | 20.03 | 18.27 | 20.20 | 23.43 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.48 | 2.78 | 3.02 | 2.87 | 3.51 | 4.50 | 3.61 | 3.29 | 3.23 | 3.50 |
| EV / EBITDA | 9.49 | 12.63 | 20.60 | 21.06 | 21.62 | 17.93 | 21.00 | 17.44 | 15.61 | 15.08 | 16.33 |
| EV / EBIT | 11.26 | 15.13 | 40.44 | 68.01 | 28.60 | 25.78 | 23.57 | 20.02 | 17.69 | 17.22 | 18.91 |
| EV / FCF | — | 23.17 | 40.86 | 23.99 | 38.11 | 27.25 | 23.42 | 28.56 | 25.83 | 30.31 | 33.23 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.2% | 45.2% | 43.0% | 39.4% | 35.8% | 43.6% | 45.6% | 43.9% | 43.7% | 44.7% | 45.2% |
| Operating Margin | 16.6% | 16.6% | 10.2% | 11.1% | 10.1% | 16.7% | 18.8% | 17.8% | 18.4% | 18.7% | 18.5% |
| Net Profit Margin | 11.4% | 11.4% | 3.9% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% | 11.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 166.3% | 166.3% | 63.6% | 26.7% | 69.9% | 94.7% | 128.0% | 127.6% | 129.8% | 167.1% | 312.3% |
| ROA | 14.3% | 14.3% | 4.8% | 2.5% | 7.4% | 11.3% | 16.6% | 16.1% | 17.1% | 15.4% | 14.9% |
| ROIC | 27.6% | 27.6% | 17.7% | 18.7% | 15.2% | 27.8% | 30.1% | 26.7% | 31.3% | 37.0% | 38.7% |
| ROCE | 30.1% | 30.1% | 17.6% | 19.6% | 16.6% | 27.0% | 29.8% | 29.4% | 34.0% | 39.0% | 37.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 5.98 | 5.98 | 5.90 | 7.54 | 4.26 | 5.35 | 3.44 | 4.80 | 3.42 | 4.05 | 7.78 |
| Debt / EBITDA | 2.06 | 2.06 | 3.03 | 2.76 | 3.29 | 2.20 | 2.17 | 2.08 | 1.92 | 1.71 | 1.88 |
| Net Debt / Equity | — | 5.63 | 5.49 | 6.59 | 4.01 | 4.81 | 2.48 | 4.60 | 3.24 | 3.28 | 6.43 |
| Net Debt / EBITDA | 1.94 | 1.94 | 2.82 | 2.41 | 3.10 | 1.98 | 1.56 | 2.00 | 1.82 | 1.39 | 1.55 |
| Debt / FCF | — | 3.57 | 5.59 | 2.75 | 5.46 | 3.01 | 1.74 | 3.27 | 3.02 | 2.79 | 3.15 |
| Interest Coverage | 13.25 | 13.25 | 5.42 | 3.64 | 6.73 | 10.09 | 12.97 | 11.56 | 13.40 | 12.74 | 12.99 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | 0.84 | 1.03 | 0.95 | 0.97 | 0.89 | 1.42 | 0.91 | 1.09 | 0.84 | 0.95 |
| Quick Ratio | 0.57 | 0.57 | 0.63 | 0.59 | 0.54 | 0.52 | 1.10 | 0.55 | 0.67 | 0.58 | 0.67 |
| Cash Ratio | 0.09 | 0.09 | 0.13 | 0.19 | 0.10 | 0.16 | 0.61 | 0.08 | 0.11 | 0.23 | 0.26 |
| Asset Turnover | — | 1.28 | 1.23 | 1.24 | 1.15 | 1.16 | 1.08 | 1.21 | 1.21 | 1.31 | 1.28 |
| Inventory Turnover | 7.44 | 7.44 | 6.35 | 6.44 | 6.04 | 5.51 | 8.06 | 6.81 | 6.82 | 7.19 | 7.13 |
| Days Sales Outstanding | — | 42.18 | 35.76 | 33.99 | 34.97 | 30.03 | 35.19 | 37.06 | 35.76 | 34.53 | 36.05 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 5.6% | 4.0% | 3.5% | 3.0% | 3.3% | 2.4% | 1.9% | 2.5% | 2.5% | 2.4% | 2.2% |
| Payout Ratio | 74.3% | 74.3% | 212.5% | 391.3% | 123.6% | 78.6% | 56.8% | 59.8% | 54.7% | 58.8% | 61.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.5% | 5.4% | 1.6% | 0.8% | 2.6% | 3.1% | 3.4% | 4.1% | 4.6% | 4.0% | 3.6% |
| FCF Yield | 7.2% | 5.1% | 2.8% | 4.7% | 3.1% | 4.1% | 4.6% | 4.0% | 4.4% | 3.6% | 3.3% |
| Buyback Yield | 3.2% | 2.2% | 0.0% | 0.0% | 0.1% | 4.0% | 0.9% | 3.3% | 1.5% | 1.0% | 1.4% |
| Total Shareholder Yield | 8.7% | 6.3% | 3.5% | 3.0% | 3.4% | 6.4% | 2.8% | 5.8% | 4.1% | 3.4% | 3.6% |
| Shares Outstanding | — | $124M | $125M | $124M | $124M | $127M | $128M | $130M | $132M | $132M | $132M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CLX stock.
The Clorox Company's current P/E ratio is 13.4x. The historical average is 32.9x. This places it at the 3th percentile of its historical range.
The Clorox Company's current EV/EBITDA is 9.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.7x.
The Clorox Company's return on equity (ROE) is 166.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 115.9%.
Based on historical data, The Clorox Company is trading at a P/E of 13.4x. This is at the 3th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
The Clorox Company's current dividend yield is 5.56% with a payout ratio of 74.3%.
The Clorox Company has 45.2% gross margin and 16.6% operating margin. Operating margin between 10-20% is typical for established companies.
The Clorox Company's Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
High leverage and negative equity
Metrics are mathematically derived from official filings.
Leverage Spikes as Equity Erodes
Debt-to-equity surged to 21.9x in Q4 2026 from 5.98x a year earlier, per reported balance sheet data, as equity collapsed to $90 million, signaling severe undercapitalization.
The $2.6 billion increase in total debt, combined with a near-zero equity base, has pushed leverage to levels that appear unsustainable. Interest coverage of 4.87x in Q4 2026, down from 19.64x in Q4 2025, suggests that debt service is becoming less comfortable, though still manageable in the near term. Investors should monitor whether the company can generate sufficient cash flow to service this debt without further eroding equity.
Liquidity Cushion Thins Dangerously
Current ratio fell to 0.66 in Q4 2026 from 0.84 a year earlier, with cash at $143 million, per reported figures, indicating a shrinking liquidity buffer that may strain under stress.
The quick ratio of 0.38 in Q4 2026 highlights a heavy reliance on inventory to meet short-term obligations, which could be problematic if demand softens or supply chains disrupt. With current liabilities exceeding current assets, the company appears vulnerable to a sudden cash crunch, especially given the elevated debt load and ongoing operational risks. This thin liquidity position warrants close monitoring, as any further deterioration could limit financial flexibility.
Working Capital Efficiency Improves
Cash conversion cycle improved to -34 days in Q4 2026 from -25 days a year earlier, per reported data, driven by extended payables, indicating stronger supplier leverage.
The negative cash conversion cycle reflects the company's ability to collect cash from customers before paying suppliers, a structural advantage in the consumer staples space. DPO extended to 122 days in Q4 2026 from 116 days in Q4 2025, while DSO remained stable at 34 days, suggesting the company is stretching supplier terms without sacrificing receivables collection. This efficiency helps offset some of the strain from high leverage, though it may not be sustainable if suppliers push back.
Margins Recover but Remain Below Peak
Gross margin slipped to 41.3% in Q4 2026 from 46.5% a year earlier, per financial statements, while operating margin was flattered by a one-time SG&A credit, masking underlying pressure.
The reported operating margin of 52.5% in Q4 2026 is distorted by a $235 million SG&A credit, which obscures the true earning power. Excluding this item, underlying operating margin appears closer to the mid-teens, consistent with the prior quarter's 17.0%. Net margin of 8.4% in Q4 2026 is below the 16.7% reported in Q4 2025, indicating that profitability is still recovering from the cyberattack and input cost inflation. Investors should focus on normalized margins, which suggest a stable but not expanding profit profile.
ROIC Volatile but Trending Up
ROIC improved to 17.0% in Q4 2026 from 10.3% a year earlier, per reported figures, though quarterly swings from 2.9% to 17.0% indicate instability in capital efficiency.
The wide range in ROIC over the past ten quarters reflects the disruptive impact of the cyberattack and subsequent recovery, as well as the volatile earnings base. The Q4 2026 ROIC of 17.0% is flattered by the one-time SG&A credit, and the underlying return on capital is likely closer to the mid-single digits. ROE of 94.8% in Q4 2026 is artificially inflated by the tiny equity base, making it an unreliable measure of shareholder value creation. Investors should rely on ROIC, which, despite volatility, suggests the company is generating returns above its cost of capital on an adjusted basis.
Misapplied ROE Obscures Leverage Risk
ROE of 94.8% in Q4 2026 is misleading due to a $90 million equity base, per balance sheet data, making it a poor gauge of performance.
The most commonly misapplied ratio for CLX is return on equity, as the near-zero equity base from cumulative losses and buybacks inflates ROE to levels that do not reflect underlying profitability. A more appropriate metric is return on invested capital (ROIC), which accounts for the company's debt and provides a clearer picture of operating efficiency. Investors should adjust for one-time items and use ROIC to assess whether the company is truly creating value above its cost of capital, rather than being misled by a distorted ROE.